BIOPSYN : cohorte multicentrique française de biopsies synoviale réalisées en pratique clinique
J. Herman, Benoît Le Goff, Nicolas Poursac(Centre Hospitalier Universitaire de Bordeaux), Adeline Ruyssen‐Witrand(Centre Hospitalier Universitaire de Toulouse), S. Trijau(Hôpital Sainte-Marguerite), B. Jamard(Hôpital Paule de Viguier), P. Buchlin(Hôpital Émile-Roux), G. Mouterde(Hôpital Lapeyronie), Charline Rinkin(Centre Hospitalier Universitaire de Bordeaux), Géraldine Bart(Centre Hospitalier Universitaire de Rennes), Jean-David Albert, Grégoire Cormier(Roche (Switzerland)), Guillaume Coiffier, Aurélie Najm(University of Liverpool), R. Brault(Centre Hospitalier Universitaire de Poitiers), Christelle Darrieutort‐Laffite(Inserm), Karine Louati(Sorbonne Université), Emmanuel Chatelus(Laboratoire National de Référence), Johann Césini(Centre Hospitalier Universitaire de Caen Normandie), O. Mérot(Centre Hospitalier Saint-Nazaire), L. Benguella(CHU Dijon Bourgogne), E. Hoppé(Centre Hospitalier Universitaire d'Angers), Paul Ornetti(Inserm)
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
|The Lancet Rheumatology|2021|292
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207